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 ABSTRACT 
 
Carbon dioxide (CO2) administration is the most commonly used method of euthanasia of 
mice in research, yet questions remain regarding whether CO2 euthanasia is associated with pain 
and stress. This study aims to characterize the level of pain and stress induced in mice during 
CO2 euthanasia, and to determine if premedication with acepromazine or midazolam, or 
anesthetic induction with isoflurane, alters these levels during CO2 euthanasia. Mice were 
assigned to one of six euthanasia groups: (control) CO2 only at a flow rate that displaces 20% of 
the cage volume per minute (V/min); premedication with acepromazine (5 mg/kg), midazolam (5 
mg/kg), or saline followed by 20% V/min CO2; induction with 5% isoflurane followed by > 
100% V/min CO2; or 100% V/min CO2 only. Behavioral measures of stress included ultrasonic 
sound recordings and analysis of video recordings, by an observer blinded to group identity, to 
assess increased respiratory effort, increased activity, and pain. Physiological parameters of 
stress were assessed by measuring plasma adrenocorticotropic hormone (ACTH) and 
corticosterone levels immediately post-euthanasia. Finally, we assessed the acute neuromolecular 
marker of pain and stress, c-fos, by quantitative PCR. The use of premedication with 
acepromazine or midazolam did not significantly alter behavioral indicators of stress but did 
significantly induce a higher level of c-fos expression in the brain compared to 20% V/min CO2 
alone. Furthermore, the use of isoflurane induction prior to CO2 euthanasia significantly 
increased stress in the mice based on both behavioral and neuromolecular indicators. These data 
strongly indicate that in comparison to the other modalities analyzed in this study, 20% V/min 
CO2 is a humane, rapid euthanasia method that is not associated with significant pain or stress in 
mice. iii 
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CHAPTER ONE: 
INTRODUCTION 
 
  Carbon  dioxide  (CO2)  administration  is  a  frequently  used  form  of  euthanasia  in 
laboratory mice due to its ease of use, availability, low expense, and high level of personnel 
safety (3; 12). Furthermore, there is no need to handle or manipulate mice prior to euthanasia, 
thereby minimizing any additional handling stress. However, questions remain with respect to 
the level of pain and stress that mice experience during CO2 euthanasia (12; 24; 41). 
  CO2  stimulates  receptors  in  the  nasal  mucosa  (62).  Pain  associated  with  this 
stimulation is concentration dependent and studies in humans indicate that one full breath of CO2 
at concentrations ranging from 50 to 100% can induce pain (14). Human subjects have reported 
that  exposure  to  50%  CO2  induced  tingling  sensations  and  that  it  was  associated  with  an 
unpleasant odor or taste; however, high CO2 concentrations (100%) induced pain which was 
variably described as piercing or stabbing (14). Rodents, like humans, posses these receptors in 
the nasal mucosa (62). Rodent studies assessing the use of CO2 as a euthanizing agent are less 
clear, and some suggest that CO2 induces pain and stress while others indicate there are no signs 
of pain or stress (12; 14; 24). 
   Concerns over the use  of CO2  have led the Canadian Council for Animal  Care 
(CCAC) to recommend the use of an inhalant pre-anesthetic followed by CO2 for euthanasia of 
rodents (10). Additionally, the Morris Animal Foundation does not consider the use of CO2 alone 
to be an appropriate method of euthanasia and will not fund projects that propose to use CO2 for 
euthanasia  without  premedication  (52).  In  some  larger  species,  pre-medication  prior  to 2 
 
euthanasia  is  standard  practice;  however,  the  potential  benefit  of  this  practice  has  not  been 
prospectively  analyzed  in  mice.  Therefore,  we  tested  the  hypothesis  that  pre-anesthetics  can 
alleviate pain and stress associated with CO2 euthanasia.  Specifically, we evaluated three pre-
anesthetics to determine if their use before euthanasia would affect behavioral, physiological or 
neuromolecular indicators of pain and stress during CO2 euthanasia. Additionally, we evaluated 
the effect of high (100% V/min) and low (20% V/min) flow rate of CO2. Behavioral measures of 
pain and stress analyzed in this study included ultrasonic sound recordings and video recordings 
examined  post-hoc  by  a  blinded  observer  trained  in  assessing  pain  and  stress  in  rodents.  
Physiological parameters of stress measured in this study included plasma adrenocorticotropic 
hormone (ACTH) and corticosterone levels. Neuromolecular assessment of pain and stress was 
evaluated from fresh brains utilizing quantitative PCR (qPCR) detection of c-fos mRNA, a well 
established immediate early brain marker of pain and stress (26; 33; 72). 
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CHAPTER TWO: 
LITERATURE REVIEW 
 
Existing Recommendations for the CO2 Euthanasia of Rodents 
According to the 2007 American Veterinary Medical Association (AVMA) Guidelines on 
Euthanasia, CO2 euthanasia should only be performed using a compressed CO2 gas cylinder.  In 
addition, the optimal flow rate of CO2 should displace at least 20% of the euthanasia chamber 
volume per minute  (V/min) (1). The American College of Laboratory Animal Medicine has 
issued a report of rodent euthanasia that states a similar recommendation (3).  Specifically, CO2 
should be added to existing room air in the euthanasia chamber at a fill rate of 20% of the 
chamber  V/min  in  order  to  achieve  a  balanced  gas  mixture  that  will  provide  rapid 
unconsciousness with minimal distress to the animals. 
In Canada, recommendations differ in regard to CO2 euthanasia of rodents. According to 
the Canadian Council on Animal Care in Science (CCAC), CO2 should not be used when other 
methods of euthanasia are practical for the species and the experiment. However, if CO2 is used, 
whenever practical, animals should be anesthetized, preferably using an inhalant anesthetic, prior 
to CO2 exposure. Furthermore, if CO2 must be used without prior anesthesia, a gradual-fill rate 
of 20% to 30% of the chamber V/min should be used (10). 
 
CO2 as a Pain Stimulus 
The controversy over the use of CO2 for euthanasia stems from the ability of inhaled CO2 
to induce pain in humans (2; 14; 30; 38) and rodents (40; 62; 75). When CO2 comes into contact 4 
 
with moisture on the nasal or oral mucosa it forms carbonic acid which stimulates nociceptors in 
the mucosa and triggers pain via the trigeminal nerve (40). Rodents, like humans, have been 
shown to have these nociceptors in the nasal mucosa (62).   
In human studies that assess CO2 as a pain stimulus, specific concentrations of CO2 are 
delivered directly to the nasal cavity through either a face mask or Teflon tube (2; 14; 30; 38). In 
one study, human volunteers were asked to rate the degree of discomfort associated with one full 
breath of 50 to 100% CO2 mixed with oxygen (14). The volunteers reported that increasing 
concentrations  of  CO2  were  progressively  more  noxious,  with  50%  CO2  being  considered 
“highly unpleasant” bordering on “uncomfortable” and 100% CO2 being rated as “painful”. In 
another study, a series of stimuli (2s duration) that consisted of 5 to 100% CO2 were applied 
directly  to  the  nasal  cavity  via  a  Teflon  tube  at  5%  increments  in  either  an  ascending  or 
descending series (2). The average individual pain thresholds ranged from 32.5 to 55.0% CO2 
(mean 47.1%). 
Rodent studies that use CO2 as a pain stimulus also apply specific concentrations of CO2 
directly to the nasal cavity while the animal is under anesthesia (40; 62; 75). One such study in 
rats examined the activity of chemonociceptive medullary dorsal horn neurons in response to 
noxious  chemical  stimulation  using  pulses  of  CO2  applied  to  the  nasal  mucosa  (75).  The 
response  threshold  of  most  of  the  neurons  tested  ranged  from  37  to  50%  CO2,  which 
corresponded closely with a human study that used a similar CO2 stimulus delivery device in 
which a mean pain threshold of 47% was obtained (2; 75). 
Nociceptor electrical responses have been recorded from the nasal respiratory epithelium 
in response to CO2 exposure in both humans (76) and rats (75). Through the application of 
electrodes in the nasal septum of human volunteers, negative mucosal potentials (NMPs) were 5 
 
recorded  during  stimulation  of  the  trigeminal  nerve  by  a  number  of  noxious  stimuli 
(isoamylacetate, acetaldehyde, CO2), but not following stimulation of the olfactory nerve with 
hydrogen sulphide (76).  The NMPs are thought to be a summation of chemosensitive nociceptor 
potentials  of  the  trigeminal  nerve.  Both  increasing  CO2  stimuli  duration  and  concentration 
caused a significant increase in NMP amplitudes and area under the curve. In addition, NMPs 
were restricted to the site of stimulated receptors in that they were only recorded from the nostril 
that received the CO2 and not the contralateral nostril. In a similar study conducted in rats, NMPs 
were recorded from the nasal respiratory mucosa following stimulation with CO2 (75). Local 
administration of topical analgesia (capsaicin and lidocaine) eliminated the NMPs during CO2 
exposure,  supporting  the  theory  that  NMPs  are  the  result  of  chemosensitive  nociceptor 
activation. 
These studies have been used to support the finding that CO2 euthanasia is not humane 
through the argument that similar concentrations to those used for euthanasia have been used to 
elicit pain (12; 41; 57; 58; 75).  However, this argument fails to account for the method in which 
CO2 is delivered in pain studies.  Specifically, in the pain studies, set concentrations of CO2 are 
applied directly to the nasal mucosa, whereas euthanasia guidelines in the USA and Canada 
recommend that rodents be euthanized using a gradual fill method of CO2 exposure, thereby 
exposing the animals to a gradual increase in CO2 concentration.  Additionally, the average pain 
threshold for CO2 concentration was between 32.5 to 55.0% in humans (2) and 37.0 to 50.0% in 
rats (based on nociceptor stimulation) (75). Using the recommended CO2 fill rate of 20 – 30% 
chamber V/min allows the rodents to be partially sedated or unconscious prior to being exposed 
to pain-eliciting concentrations of CO2 (1; 3; 10). 
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Approach – Avoidance Testing 
Approach-avoidance  tests  are  used  to  determine  an  animal’s  relative  aversion  to  a 
particular stimulus, such as CO2 exposure (35). A set level of food deprivation occurs prior to 
testing. During the test, food rewards are made available to the animal during exposure to gas 
stimuli.  If  the  hungry  animal  is  unwilling  to  tolerate  the  stimulus  for  food,  the  stimulus  is 
considered aversive. This test is based on an assumption of additivity in that tolerance of an 
aversive stimulus should increase as the level of hunger increases (35). 
The approach-avoidance test involves housing the animal in the test apparatus which 
consists of two transparent cages with wire lids that are connected by a sloped opaque tunnel 
(Figure 1) (58). The top home cage contains bedding, food and water and the bottom test cage 
contains just bedding.  The animal has access to both cages.  Prior to the experiment, the animal 
is  trained  to  enter  the  test  cage  to  receive  a  food  reward.    During  the  experiment,  the  test 
apparatus is moved to a fume hood and the wire lid on the test cage is replaced with an acrylic lid 
fitted with a gas inlet in the center, two air outlets at the end of the cage closest to the tunnel, and 
a gas sampling tube at the end of the cage opposite the tunnel (Figure 1). Initially, the animal is 
locked in the home cage.  After the lock is removed, the animal is able to enter the test cage for a 
food reward, such as 20 pieces of sugared cereal.  As soon as the animal enters the test cage and 
starts eating, either air or the test gas is initiated at a pre-determined rate. The test ends once the 
animal leaves the test cage, and percentage of gas in the cage (as determined through the gas 
sampling tube), time to exit the test cage, and amount of food eaten can be used as measures of 
aversion to the test gas (58).  7 
 
 
Figure 1: Approach – Avoidance Test Experimental Apparatus. See text for details. 
 
Many studies that argue against the use of CO2 euthanasia use an approach-avoidance test 
to measure how aversive CO2 is to rodents (36; 45; 57; 58). In one such experiment, rat aversion 
to CO2 was tested by examining rats’ responses to static CO2 concentrations of 5, 10, 15, and 
20% (58). For static exposure, the test cage was pre-filled with the designated concentration of 
CO2 before the rats were given access. At static CO2 concentrations of 5 and 10%, the rats ate all 
20 food reward items. There was a significant decrease in time spent in the test cage and number 
of food items eaten with 15 and 20% CO2.  At 20% CO2 the majority of rats refused to eat and 
left the test cage immediately. When the rats were exposed to a gradual fill of CO2 at a flow rate 
of 17% of the chamber V/min, they stopped eating and left the cage when the chamber CO2 
concentrations reached on average 17.3 ± 2.1% and 18.4 ± 2.0%, respectively (58). In a similar 8 
 
study, mice exposed to a CO2 flow rate of 18% of the chamber V/min left the test cage on 
average at a CO2 concentration of 18.2 ± 2.0% (45). 
However, a study that tested the validity of using an approach-avoidance test to measure 
the strength of aversion to CO2 in rats found that when food deprivation prior to testing exceeded 
seven hours, hunger made the rats less willing to tolerate  CO2 exposure for food instead of 
motivating them to stay longer (35).  The authors attributed these results to increased anxiety due 
to hunger and therefore cautioned the use of food deprivation to assess the strength of aversion to 
CO2 (35). While these studies do use a gradual fill method of introducing the gas to the rodents, 
the test ends once the rodent chooses to leave the gas chamber and euthanasia is not a part of the 
study.  These studies confirm that exposure to CO2 is more aversive than a particular food item is 
attractive; however, aversion does not indicate pain or stress. In fact, other approach-avoidance 
studies use stimuli that are aversive to rodents but would not be considered painful or stressful, 
such  as  a  brief  puff  of  air  (77).  Furthermore,  aversive  responses  in  female  mice  have  been 
demonstrated  in  mate  preference  tests  in  which  mice  have  been  shown  to  display  aversive 
responses to odors of male mice that are infected with the murine louse, Polyplax serrata, which 
demonstrates that aversive behaviors do not only coincide with pain and/or stress (32).  
Additionally,  the  CO2  approach-avoidance  studies  fail  to  adequately  account  for  the 
evolutionarily conserved avoidance response to hypoxia. Specifically, avoidance of a hypoxic 
environment  can  be  demonstrated  in  organisms  as  primitive  as  nematodes  (Caenorhabditis 
elegans), which lack the cognitive or anatomic features necessary to experience pain as it is 
currently defined (7). Hypoxia avoidance has also been demonstrated in fish that will not tolerate 
hypoxic conditions to reach a food source (28; 44) and in rats that will avoid carbon monoxide, 
which has not been found to be painful in humans, in an approach-avoidance test (46). 9 
 
Argon as an Alternative to the use of Carbon Dioxide 
  Argon (Ar) is an odorless, inert, non-flammable, and non-explosive gas, which unlike 
CO2, is non-irritating to the nasal mucosa and therefore has been suggested as an alternative to 
CO2 euthanasia of rodents (1; 58). Mouse and rat aversion to Ar (93.7 to 99.2%) was compared 
to  CO2  (25.5  to  50.8%)  and  a  CO2/Ar  mixture  (15.5  to  59.2/5%)  (41).    The  test  apparatus 
consisted of one test chamber that was prefilled with a specific gas concentration and connected 
to either one regular air chamber (rats) or four regular air chambers, one on each side (mice). No 
food reward was provided in the test chamber and animals had free range of the test chamber and 
all regular air chambers.  The animals were introduced into the test apparatus via a flap in one of 
the connecting tubes near the entrance to the test chamber.  Each test lasted three minutes and 
initial withdrawal time from the test chamber and total dwelling time in the test chamber were 
measured as indicators of aversion for each of the gases. Results from this study suggested that 
Ar was less aversive to both mice and rats than either CO2 alone or a CO2/Ar mixture based on 
longer withdrawal times and total dwelling times within the test chamber.   
  As a follow up to the previous study, an approach – avoidance test was performed to test 
rat aversion to Ar compared to CO2 when each gas was paired with a food reward (58). In this 
study, rats were tested with a gradually increasing concentration of CO2 at a flow rate of 17% of 
the chamber V/min, slightly lower than current CO2 euthanasia recommendations (1; 3; 10), and 
a static concentration of 90% Ar, which is a suggested replacement for CO2 euthanasia (58). 
During CO2 exposure, rats stopped eating and left the test chamber when CO2 concentrations 
reached 17.3 ± 2.1% and 18.4 ± 2.0%, respectively. However, when the test chamber contained 
90% Ar, no rats ate the food and they either refused to enter or left the test chamber immediately.  
Results of this study indicate that Ar is more aversive for rats when exposure is consistent with 10 
 
euthanasia recommendations for each gas.  These findings contradict the previous study (41) 
which did not take into account the gradual fill recommendation for CO2 euthanasia. 
  Finally, euthanasia of rats using Ar at 50% chamber V/min was compared to euthanasia 
using CO2 at 10% chamber V/min by assessing heart rate and behavior (9). The heart rate of rats 
exposed to Ar did not change, whereas the heart rate of rats exposed to 10% chamber V/min CO2 
declined significantly, likely due to the sedative properties of CO2. Additionally, rats euthanized 
with Ar gasped and demonstrated seizure-like activity, both of which were not seen in the CO2 
euthanized group. The authors concluded that Ar as a sole euthanizing agent was highly aversive 
to rats, whereas 10% chamber V/min CO2 did not result in any overt behavioral indicators of 
distress (9).  
Overall, these findings suggest that Ar is not a suitable replacement for CO2 euthanasia. 
Additionally, according the 2007 AVMA Guidelines on Euthanasia, rodent euthanasia using Ar 
is only conditionally acceptable when oxygen concentrations below 2% are achieved rapidly and 
the  animals  are  heavily  sedated  or  anesthetized,  therefore  other  methods  of  euthanasia  are 
preferable (1). 
 
Isoflurane Anesthesia Prior to CO2 Euthanasia 
According to the CCAC euthanasia guidelines, whenever practical, animals should be 
anesthetized,  preferably  using  an  inhalant  anesthetic,  prior  to  CO2  euthanasia  (10).  The  two 
studies  that  were  cited  in  support  of  this  recommendation  used  approach-avoidance  tests  to 
assess  rodent  aversion  to  gas  stimuli  (41;  47).  However,  one  study  assessed  rat  and  mouse 
aversion to pre-filled chambers of CO2, CO2/Ar mixture, or Ar without the presence of a food 
reward in the test chamber (41), while the other study compared rat aversion to gradual fill 11 
 
halothane or isoflurane with a food reward in the test chamber (47). In the CO2/Ar study, the 
authors concluded that induction with CO2 either alone or in combination with Ar is likely to 
cause considerable distress in rodents before they lose consciousness  (41). This finding was 
based upon significantly shorter initial withdrawal times and total dwelling times in the test 
chamber that was pre-filled with CO2 at concentrations that ranged from 25.5 to 50.8% compared 
to  the  control  of  room  air.  The  halothane/isoflurane  study  concluded  that  both  inhalant 
anesthetics were aversive to rats (47).  However, because some of the rats remained in the test 
cage long enough to become ataxic, the authors concluded that the rats were likely in a state of 
partial sedation at the time they chose to leave the test cage, therefore, continued forced exposure 
from the onset of aversion to unconsciousness may be more humane than forced exposure to 
CO2. The two studies were not comparable in their design (pre-fill vs. gradual fill; no food 
reward vs. food reward), and neither study directly compared aversion of CO2 to isoflurane.  
In an approach-avoidance study that did assess both CO2 and isoflurane, isoflurane was 
still found to be less aversive than CO2 (45). On average, mice left the test cage when CO2 
concentrations were between 13.5 and 18.2%, and no mice remained long enough to become 
recumbent. Mice remained in the test cage longer with exposure to isoflurane and two out of six 
mice remained long enough to become recumbent. 
A major drawback of all these studies is that they do not involve euthanizing the rodents 
or assess any direct or indirect indicators of pain or stress. Further studies that directly assess the 
use  of  isoflurane  anesthesia  prior  to  CO2  euthanasia  are  needed  to  determine  if  this 
recommendation is justified as a more humane method of euthanasia over the use of CO2 alone. 
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Behavioral Assessment of Pain and Distress 
Pain is a perceived unpleasant sensory and emotional experience that results from actual 
or potential tissue damage (6). Pain can result from a physiologic stressor such as injury, surgery, 
or disease; it can result from an environmental stressor such as chemical or thermal; and it can be 
potentiated by a psychological stressor such as fear and anxiety (56).  Distress is an aversive 
state which occurs when an animal is unable to fully adapt to a stressful situation and the stress 
manifests itself in  the form  of maladaptive behaviors  (56).  For example, in  mice distressful 
maladaptive behaviors may include decreased food intake, lack of grooming, inappropriate social 
interactions,  or  poor  reproductive  performance.  Distress  can  also  manifest  in  physiologic 
conditions such as gastrointestinal ulceration, hypertension, and immunosuppression.  
Stress  refers  to  the  effect  of  external  or  internal  stressors  on  an  animal’s  biologic 
equilibrium  (56).    External  stressors  may  refer  to  a  physical  event  such  as  restraint,  or 
environmental  factors  such  as  noise,  odor,  temperature,  or  the  presence  of  people  or  other 
species.    Internal  stressors  may  include  physiologic  factors  such  as  injury  or  disease,  or 
psychological factors such as fear, anxiety or loneliness.   Not all stress is ultimately bad; in fact, 
it may initiate a response that has potential beneficial effects, such as moving on to a new habitat 
that has better food resources or less predation. Depending on how well an animal is able to 
cope, both pain and non-pain stressors may result in either stress or distress. An animal will use 
behavioral  and/or  physiological  coping  mechanisms,  such  as  activation  of  the  sympathetic 
nervous  system  and  the  hypothalamic-pituitary-adrenal  axis,  to  adapt  and  counteract  the 
disruption to its state of equilibrium. Making the distinction between stress and distress is an  
important consideration when evaluating animal welfare since an animal experiencing a brief 
episode of stress is very different from an animal in distress. 13 
 
Determining  whether  an  animal  is  experiencing  pain  or  stress  is  a  challenge  due  to 
differences in behavioral responses to noxious stimuli between and within species, and the lack 
of validation between a particular response and the underlying cause. Typically, a change from 
an individual animal’s normal behavior is used as an indication of pain or stress. Examples of 
pain or stress related changes in behavior include: decreased locomotion, decreased grooming, 
indifference to surroundings, inappetence, and decreased fecal output (39). However, even these 
behaviors are not invariably indicative of pain or stress. To make things simpler, in assessing 
animal welfare, pain and stress are generally discussed together since either one can compromise 
welfare and need to be avoided. However, to complicate things further, normal behavior does not 
indicate a pain or stress-free state, especially in prey species which need to continue normal 
behavior as long as possible to avoid predation or disruption of the social hierarchy.  
Assessing whether an animal is experiencing pain and/or stress is further complicated by 
the subjective nature of such observations. The controversy regarding the humaneness of CO2 
euthanasia centers on the difficulty in interpreting behavioral responses of animals during CO2 
exposure.  Different observers draw different conclusions concerning the same animal behaviors, 
some conclude that no pain or stress was observed while others conclude that significant pain or 
stress was evident. Each study that uses behavioral observations to assess pain or stress has its 
own criteria of behavioral indicators. The behaviors assessed are not consistent across studies, 
thereby  making  comparison  across  studies  difficult.  In  addition,  an  association  between  the 
behavior described and an underlying cause, such as pain or stress, may not have been validated, 
again making the interpretation of a particular behavior subjective. 
  In one study that evaluated CO2 euthanasia of rats, assessment of behavior was based on 
the appearance of the rat’s eyes, respiration, overall appearance, defecation, urination, abnormal 14 
 
activity,  locomotion  and  vocalization  (24).  The  authors  described  three  distinct  phases  of 
behavioral patterns during CO2 euthanasia.  In the initial period of gas exposure, rats showed 
tachypnea and a higher attention span, with no vocalization, urination or defecation.  They also 
interpreted  no  signs  of  pain  due  to  the  lack  of  sneezing  and  tears.    The  second  phase  was 
characterized by continuation of tachypnea, but a lack of movement in which the rats sat quietly 
and  showed  reduced  attention  to  their  environment.  In  the  final  phase,  the  rats  appeared 
unconscious  with  total  muscle  relaxation.    While  these  behavioral  parameters  and  their 
interpretation  appear  reasonable,  there  are  no  studies  to  validate  their  interpretation.  While 
chromodacryorrhea  has  been  associated  with  pain  and  stress  in  rats,  the  lack  of  porphyrin 
secretion does not verify an absence of pain or stress.  In a rat restraint trial, in which rats were 
loosely wrapped with porous adhesive tape in such a way that both forelimbs were bound to the 
thorax, latency from restraint to chromodacryorrhea ranged from 3 to 40 minutes (25). This 
finding  indicates  that  even  if  CO2  exposure  was  enough  of  a  noxious  stimulus  to  cause 
chromodacryorrhea, the duration of exposure prior to death may be too short. Tachypnea is a 
biological response to hypoxia and therefore cannot invariably be attributed to pain or stress. 
Defecation and urination are such frequent occurrences in rodents that it is difficult to attribute 
either to pain or stress. Abnormal activity and locomotion are probably the best indicators a 
change  from  the  animal’s  normal  behavior,  although  this  is  subjective.    Since  ultrasonic 
recordings were not a part of this study design, it is unclear if ultrasonic vocalizations were 
present and undetected. Because of all the questions that can be raised by behavioral analyses, 
responses need to be interpreted in conjunction with more objective and quantifiable data. In the 
rat CO2 euthanasia study (24), serum concentrations of glucose, ACTH and corticosterone were 
analyzed and were consistent with the authors’ behavioral interpretation of no pain or distress. 15 
 
Additionally,  rats  that  were  either  sedated  with  acepromazine  or  anesthetized  with 
pentobarbiturate  prior  to  CO2  euthanasia  had  similar  hormone  levels  as  the  conscious  rats, 
indicating no increase in pain or stress in the conscious animals during CO2 euthanasia. 
  In  a  study  comparing  the  behavioral  and  cardiovascular  responses  of  rats  to  rapid 
induction or gradual fill CO2 euthanasia, behavioral parameters that were assessed included: 
head  raising,  vocalization,  escape,  tail  lashing,  gait,  circling,  twitching,  recumbency, 
urination/defecation,  and  respiration  (71).  Rats  displayed  inquisitive  behaviors,  followed  by 
labored breathing and death. Two of the four rats exposed to rapid induction showed head raising 
behavior at the beginning of the procedure, but this was interpreted as disorientation due to 
anoxia, and was not considered an indicator of stress. There was no incidence of vocalization, 
escape attempts or tail lashing.  Again there was no report of using ultrasonic recordings to 
capture any ultrasonic vocalizations. Gait, circling, twitching, recumbency, and respiration were 
assessed more to describe phases of behavior during CO2 euthanasia rather than as measures to 
detect  stress.    The  study  included  measures  of  pulse  rate  and  blood  pressure  as  objective 
measures, both rapidly dropped below control baseline levels, which was consistent with rapid 
central  nervous  system  depression  instead  of  stress  which  would  be  expected  to  raise  both 
measures. The authors concluded that no overt behavioral signs of pain or distress were apparent 
in either group.   
  Behavioral measures of pain and stress are important components of any CO2 euthanasia 
welfare study; after all, the animal behavior is what personnel performing the euthanasia witness. 
However, because those perceptions will vary from person-to-person, it is important to have 
quantifiable  objective  measures  to  support  conclusions  drawn  about  observed  behaviors.  
Advances  in  utilizing  behavioral  measures  may  be  possible  with  the  use  of  a  Force-Plate 16 
 
Actometer (Bioanalytical Systems, Inc., West Lafayette, IN), which is essentially an enclosure 
above a force-plate that is able to quantify animal movements within the enclosure.  This device  
can be used with both mice and rats and can quantify locomotor activity, rotation, startle, ataxia,  
and  stereotypies,  such  as  head  bobbing  and  rearing,  grooming,  scratching,  and  whole  body 
tremors (20; 78).  
 
Ultrasonic Vocalization Analysis 
Another alternative for quantifying a behavior involves the use of an ultrasonic sound 
recorder  to  capture  and  analyze  rodent  vocalizations.  Rodents  communicate  with  each  other 
through  a  series  of  vocalizations  that  are  either  within  the  human  audible  range  or  in  the 
ultrasonic  range  (>  20  kHz),  which  is  above  the  human  audible  frequency  range  (63;  68). 
Audible sounds, as in most other mammals, are produced by vibrating structures in the larynx 
(68). Ultrasonic vocalizations (USVs) are produced by expired air against a closed glottis which 
creates a whistle-like mechanism in the larynx (66). USVs in rodents are speculated to have 
evolved because they provide an intra-species highly-directional method of communication over 
a short distance without alerting predators such as birds, many of which are unable to hear 
sounds  above  25  kHz  (60).  Ultrasounds  also  have  a  high  rate  of  attenuation  and  are  easily 
deflected by small objects such as grass or twigs and even dust particles in the air, therefore even 
predators at a distance  that have ultrasonic hearing abilities are not likely to be alerted by rodent 
USVs (60). Although ultrasounds do not carry well across distances, they are easily localized 
over short distances, for example, a young rodent pup cry easily enables the mother to locate the 
pup without alerting distance predators (60). 
  Three classes of USVs have been characterized in the laboratory rat (Rattus norvegicus) 
(8; 63; 68). Infant rats emit USVs in response to a number of distressful situations such as 17 
 
separation from the dam, isolation from the nest, unfamiliar environment or odors, and thermal 
or tactile stimuli (8; 68).  Juvenile and adult rats emit two distinctive USVs, a high-pitched and 
short “50 kHz vocalization” and a low-pitched and longer “22 kHz vocalization” (42; 63; 68). 
The 22 kHz vocalizations have frequencies between 18 and 32 kHz, last 300 to 4000 ms, and are 
associated with a number of aversive situations such as exposure to a predator, inescapable foot 
shocks, startling noises, and during male-on-male aggression and social defeat (42; 63). During 
22 kHz vocalizations, rats may exhibit behaviors such as tense, motionless couching (freezing) 
and pronounced breathing, which reflect a negative affective state of the animal (63). The 50 
kHz vocalizations have frequencies between 32 and 96 kHz, last 30 to 50 ms, and are associated 
with non-aversive situations such as during sexual behaviors, juvenile play, and pleasant manual 
tactile stimulation (tickling) by investigators (63). These vocalizations have not been recorded 
during freezing behaviors and are believed to indicate a positive affective state of the animal 
(63). 
  Since USVs are an objective quantifiable measure, many studies have been conducted to 
validate vocalization as an indicator of stress (8; 23; 37; 42; 51; 60; 63; 68). Because rats will 
often produce conditioned anticipatory stress vocalization upon re-exposure to an environment in 
which they previously experienced an aversive stimulus, USV has been used as a measure to test 
the anxiolytic potential of pharmacological agents (18; 51; 68). Anxiolytic benzodiazepines, such 
as chlordiazepoxide and diazepam which reduce anxiety in humans, have been shown to reduce 
the USVs induced by tail-holding stress in rat pups at doses that had little central nervous system 
depressant activity (21). Reduction of maternal separation induced USVs has been demonstrated 
in rats using anxiolytic drugs such as benzodiazepines and serotonergic agents (51).  18 
 
While stress  vocalizations  are not  well characterized in  mice, numerous  studies  have 
successfully  used  maternal  separation  USVs  in  mouse  pups  to  test  the  anxiolytic  effects  of 
benzodiazepines and serotonergic agents (5; 18; 54; 55). As seen in rats, mouse pups treated with 
midazolam  (benzodiazepine)  or  allopregnanolone  (a  serotonergic  agent)  dose  dependently 
emitted fewer USVs than vehicle-treated pups when separated from dam and littermates (18). 
These findings support the use of USVs as a measure of stress in infant mice as well as rats; 
however, continued research needs to be conducted to further characterize the USV patterns of 
adult mice. 
 
Biochemical Indicators of Pain and Stress  
Biochemical  indicators  of  pain  and  stress  are  commonly  included  in  CO2  euthanasia 
welfare studies to provide quantifiable objective support to behavioral measures of pain and 
stress. Acute stress caused by pain or noxious stimuli results in activation of the hypothalamic-
pituitary-adrenal (HPA) axis which is a major component of the neuroendocrine system that 
controls  an  animal’s  reaction  to  stress.  The  hypothalamus  secretes  corticotrophin-releasing 
factor, which in turn stimulates the pituitary to release ACTH, which stimulates the release of 
glucocorticoids from the adrenal cortex (53). Increase in levels of glucocorticoids is an adaptive 
mechanism  that  allows  the  animal  to  cope  with  stressors  by  mobilizing  body  reserves  in 
preparation for the fight or flight response (53). ACTH and glucocorticoids reach their target 
organs  via  the  blood  stream  which  allows  for  the  evaluation  of  their  concentration  in  the 
peripheral  circulation  to be utilized as  a quantifiable biochemical  indicator of pain  or stress 
across many species (27; 53; 59; 61). However, it is important to note that increases in ACTH 
and glucocorticoids do not invariably indicate pain or stress. Equivalent levels of glucocorticoids 
have been demonstrated in stallion plasma at all time points between 0 and 30 minutes following 19 
 
sexual stimulation and stressors such as physical exercise, restraint via a twitch, and epinephrine 
administration (11). 
In rodents, corticosterone is the primary glucocorticoid produced in response to pain or 
stress, and therefore, plasma ACTH and corticosterone concentrations are commonly assessed in 
rodent studies when animal welfare is in question (61). The stress of handling has been shown to 
double the baseline level of corticosterone in rats in as little as two minutes (43). However, 
because factors other than pain or stress can affect levels of these hormones, it is important to 
interpret their concentrations in conjunction with other parameters of pain and stress. 
 
Molecular Marker of Pain or Distress 
  Neurons in the brain and spinal cord express the immediate early gene c-fos in a transient 
and rapidly induced manner in response to stimulation (15; 26; 74). While most research on c-fos  
has  been  conducted  in  rats,  studies  have  also  shown  that  noxious  stimulation  induces  c-fos 
expression in mice, fish, insects, humans, and various other species (4; 16; 34; 65; 67). Various 
types  of  noxious  stimulation,  including  chemical,  mechanical  and  thermal,  induce  elevated 
expression of c-fos (26). For example, injection of dilute formalin into a hind-foot induces an 
increase in c-fos expression consistent with nociceptive behaviors of flinching and licking of the 
injected  foot  (17).  Injection  of  dextromethorphan,  but  not  saline,  prior  to  formalin  injection 
suppresses both the increase in c-fos expression and the nociceptive behaviors, confirming that c-
fos elevation is due to nociception of the formalin and not formalin itself (17). 
Acute restraint stress has also been shown to stimulate expression of  c-fos in the rat 
cortex,  hippocampus,  hypothalamus,  septum,  and  brainstem  (50).  Similar  to  plasma 
corticosterone concentration, habituation of c-fos responses occur with repeated exposure to the 
same stress.  Specifically, c-fos expression becomes significantly smaller in animals restrained 20 
 
once daily for four days, and nonexistent in animals restrained once daily for nine days.  In 
addition, the habituation of c-fos expression is stressor specific: exposure of restraint-adapted 
rats to a novel stress, such as 20 minutes of swim time, produces an increase in c-fos expression 
comparable to rats exposed to swimming for the first time (50). Elevation of c-fos expression has 
also been shown with exposure of rats to an environment in which they had previously received 
foot  shocks  (4).  The  benzodiazepine,  Diazepam,  produces  a  dose-dependent  decrease  in 
conditioned stress-induced c-fos expression in most regions of the brain that would otherwise 
have shown increased c-fos expression (4).   
Since both nociception and stress induce activation of c-fos and the half-life is relatively 
short, expression of c-fos closely mirrors the intensity and duration of the noxious stimulus (15; 
26; 74). Therefore quantification of c-fos mRNA can be used as an additional indicator of pain 
and stress in mice. 
 
 
 
 
 
 
 
 
 
 21 
 
CHAPTER THREE: 
SEDATION PRIOR TO CARBON DIOXIDE EUTHANASIA 
MATERIALS AND METHODS 
 
Animals 
Female CD-1 mice (n=10/group; age 8 - 11 weeks of age) were purchased from Charles 
River Laboratories and acclimated for a minimum of one week prior to experimental procedures.  
All mice were screened by the vendor and were deemed specific-pathogen free for all commonly 
tested  bacterial  and  viral  pathogens  and  parasites.  All  animal  procedures  were  approved  by 
Cornell’s Institutional Animal Care and Use Committee. 
 
Housing 
Mice were housed in an AAALAC-accredited facility in groups of 2-3 in individually 
ventilated polycarbonate cages [11.5 in (l) x 6.5 in (w) x 5 in (h)], with autoclaved corncob 
bedding (7097A; Harlan Teklad, Fredrick, MD). Cages were maintained on a Micro-FLO/Micro-
VENT Environmental Rack System (Allentown Caging Equipment Company, Allentown, NJ).  
The mice were maintained in a temperature (70 ± 2 
oF) and humidity (30-70%) controlled room 
with a 14 hour light and 10 hour dark cycle.  All mice had free access to food (7912; irradiated 
maintenance  mouse  diet,  Harlan  Teklad)  and  acidified  reverse-osmosis  water  through  an 
automated watering system (Edstrom, Waterford, WI).  All cages were provided with  sterile 
nestlets for enrichment. 
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Experimental Design 
Mice were weighed the day prior to euthanasia and were randomly allocated into six 
euthanasia groups (n=10/group; Table 1). Group 1 (control) was euthanized by CO2 alone. Group 
2 received acepromazine (5mg/kg, 0.20 ml volume in sterile saline) via an intraperitoneal (IP) 
injection 10 minutes prior to euthanasia. Group 3 received midazolam (5mg/kg, 0.20 ml volume 
in sterile saline) IP 10 minutes prior to euthanasia. Group 4 received a 0.20 ml IP injection of 
saline 10 minutes prior to euthanasia (negative control for IP injection). Groups 1-4 were all 
euthanized with CO2 at a flow rate of 20% chamber air displacement per minute (20% V/min; 
1.2 L/min). Group 5 was anesthetized with 5% isoflurane at a flow rate of 1.2 L O2 per minute 
until all mice in the cage were unconscious and then immediately euthanized with CO2 at a flow 
rate of > 100% V/min (consistent with the CCAC recommendation). Group 6 was euthanized by 
CO2  at  flow  rate  of  100%  V/min  (6.1  L/min).  Flow  meter  setting  was  calculated  using  the 
following formula: (% air displacement per min) × (volume of cage in L). 
 
Table 1.  Experimental Groups of Mice. 
Group
1    Premedication
2  Displacement rate V/min  
1    None  20% 
2    5 mg/kg acepromazine 10 min prior to euthanasia  20% 
3    5 mg/kg midazolam 10 min prior to euthanasia  20% 
4    0.20 ml saline 10 min prior to euthanasia  20% 
5    5% isoflurane immediately before euthanasia
3  >100% 
6    None  100% 
1Each group included 10 mice. 
2Premedications given in 0.20 ml volume per mouse. 
3Flow rate of 1.2 L O2/min until all mice were unconscious, then euthanized with >100% CO2. 
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Behavioral measures of pain and stress.  
Separate digital video recordings and sound recordings of each cage were collected for 
approximately two minutes immediately following administration of premedication (induction), 
two minutes immediately prior to gas administration (pre-euthanasia), and for the duration of gas 
administration (euthanasia). Video recordings were collected using a Sony digital video camera 
directed at the long axis of the cage. Each video recording was assigned a random number and 
blindly scored for increased respiratory effort (a marker of dyspnea), increased locomotion (a 
behavioral marker of stress and agitation), and presence of any behaviors indicative of pain on a 
scale of 0-3 (0 = none, 1 = mild, 2 = moderate, 3 = severe) by an individual that was unfamiliar 
with the study design or the group identity. Time to unconsciousness and time to death were 
recorded for each mouse starting from the onset of CO2 exposure.  Unconsciousness was defined 
as cessation of voluntary movement, and death was defined as complete cessation of breathing.  
 
Ultrasonic sound recordings. 
Sound recordings in the range of 0-120 kHz were collected for two minutes prior to gas 
administration (pre-euthanasia) and during gas administration (euthanasia) using an ultrasonic 
microphone (USG 116 to 200 UltraSoundGate Kit, Avisoft, Berlin, Germany) to capture vocal 
emissions made by the mice. Sound recordings were recorded until the time when mice lost 
consciousness. The microphone was directed into the cage through a hole in a platform that was 
placed on top of the cage after removing the bonnet and wire rack (Figure 2). An averaged power 
spectrogram of each cage recording was created using software provided by the manufacturer 
(SASLab Pro, version 4.3, Avisoft). Sonograms from two cages of each group were averaged 
and plotted on a graph comparing pre-euthanasia and euthanasia values.   24 
 
 
Figure 2: Euthanasia Set-Up. Animals remained in the home cage and CO2 was administered 
through the lixit port (arrow) and an ultrasonic microphone was placed over the cage. 
 
Physiological measures of pain and stress.  
Immediately  following  euthanasia,  mice  were  exsanguinated  by  cardiac  puncture  and 
blood was collected in EDTA tubes.  Euthanasia of all groups was coordinated to occur at the 
same time (9-11 A.M.) in a random order to ensure no fluctuations in circadian rhythm and that 
the order of euthanasia was not a factor in the parameters analyzed. Plasma was isolated and 
stored at -20
oC until assayed for ACTH and corticosterone levels. A chemiluminescent enzyme-
linked immunosorbent assay (ELISA) (Calbiotech, Spring Valley, CA) was used to measure 
plasma ACTH levels and a competitive ELISA (VWR, Radnor, PA) was used to measure plasma 
corticosterone levels. 
 
Neuromolecular measure of pain and stress.  
A  coronal  midsection  of  brain  tissue,  including  the  hypothalamus,  was  collected  and 
processed for c-fos mRNA quantification.  Total RNA was isolated from the samples using the 25 
 
E.Z.N.A. Tissue RNA kit (Omega Bio-Tek, Inc, Norcross GA) and 1 μg of RNA was converted 
to cDNA (Quanta biosciences, Gaithersburg, MD 20877). Quantitative PCR was performed for 
c-fos and Gapdh mRNA expression utilizing SYBR/Lo Rox (Quanta biosciences, Gaithersburg, 
MD 20877) and run on an ABI Fast 7500 machine. Expression of c-fos was normalized to Gapdh 
(housekeeping gene) and analyzed using the ∆∆Ct method as described previously (49). 
 
Statistics.  
All statistical analyses were conducted using GraphPad Prism (version 5.04, GraphPad 
Software,  San  Diego,  CA).    All  parametric  data  sets,  including  time  measurements,  ACTH, 
corticosterone,  and  c-fos  mRNA  expression  were  analyzed  using  a  one-way  ANOVA  and 
Tukey’s  post-test.  Behavior  data  were  analyzed  using  a  nonparametric  Kruskal-Wallis  test 
followed by Dunn’s post-test.  All data were considered significant at P < 0.05. 
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CHAPTER FOUR: 
RESULTS 
 
Time measurements.  
Mice euthanized with 100% V/min CO2 had the most rapid loss of consciousness (39.6 ± 
1.9 s), which was significantly faster than the 20% V/min CO2, saline, and isoflurane groups (P 
< 0.05; 137.2 ± 10.5 s; 112.9 ± 12.7 s; 122.9 ± 16.0 s, respectively; Figure 3). The 100% V/min 
CO2 group also reached death (79.9 ± 4.2 s) significantly faster than all other groups, which 
ranged from 222.3 ± 22.5 to 385.2 ± 46.7 s (P < 0.05; Figure 4).  
Premedication of mice with acepromazine or midazolam significantly decreased the time 
to unconsciousness (74.5 ± 8.3 s; 71.6 ± 6.6 s, respectively) compared to 20% V/min CO2 alone 
(P < 0.05; 137.2 ± 10.5 s; Figure 3). However, premedication with midazolam significantly 
lengthened the time to death (385.2 ± 46.7 s) compared to 20% V/min CO2 alone (P < 0.05; 
234.6 ± 18.4 s; Figure 4). Induction with isoflurane did not reduce time to unconsciousness or 
death,  but  instead produced the unwanted side-effect  of  5/10  mice  recovering  consciousness 
while the cage was being treated with >100% V/min CO2.  Induction with isoflurane required a 
longer CO2 exposure time (131.1 ± 18.6 s), although not significantly, than the 100% V/min CO2 
group. 27 
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Figure 3: Time to Unconsciousness. Time (mean ± SEM) to unconsciousness was analyzed for 
each  group.  *  indicates  a  significant  decrease  in  time  compared  to  20%  V/min  CO2  and 
isoflurane; and ** indicates significantly shorter time compared to 20% V/min CO2, saline, and 
isoflurane. P < 0.05. 
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Figure 4: Time to Death. Time (mean ± SEM) to death was analyzed for each group. Despite a 
shorter  time  to  unconsciousness,  mice  euthanized  with  midazolam  experienced  a  significant 
increase in time to death compared to 20% V/min CO2. ʦ indicates a significant increase in time 
compared  to  20%  V/min  CO2,  acepromazine,  and  saline;  Δ  indicates  significant  changes 
compared to all other groups. P < 0.05. 
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Behavior analysis 
To  determine  if  any  of  the  euthanasia  methods  induced  greater  evidence  of  distress, 
blinded observations were conducted for the induction, pre-euthanasia and euthanasia periods. 
Groups of mice were compared based upon both treatment and time (induction, pre-euthanasia, 
euthanasia). Behavior scores at induction were compared between the acepromazine, midazolam, 
and saline treated groups. Induction with midazolam resulted in significantly higher agitation 
scores compared to induction with acepromazine (P < 0.05; 1.4 ± 0.3 and 0.4 ± 0.2, respectively) 
but did not differ significantly from the saline control (0.9 ± 0.1; Figure 5). Midazolam induction 
also resulted in significantly higher agitation scores compared to pre-euthanasia and euthanasia 
time points (P < 0.05; 0.3 ± 0.2 and 0 ± 0, respectively), and higher agitation scores, although not 
statistically significant, when compared to euthanasia with 20% V/min CO2 alone.  Only two 
mice received a mild (=1) pain score, one midazolam treated mouse during induction and one 
acepromazine treated mouse during pre-euthanasia (data not displayed). 
During euthanasia, the isoflurane  group  received agitation scores  (3.0  ± 0) that were 
significantly higher than the 20% V/min CO2, acepromazine, midazolam, and saline groups (P < 
0.05;  0.8  ±  0.1;  0.4  ±  0.2;  0  ±  0;  0.7  ±  0.2,  respectively;  Figure  5).  Euthanasia  caused  a 
significant increase in dyspnea (P < 0.05) in all groups of mice compared to their respective pre-
euthanasia scores, but dyspnea scores did not differ significantly between any of the euthanasia 
groups (Figure 6).  29 
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Figure 5:  Behavioral  Agitation  Scores.    A blinded observer examined videotapes  taken at 
induction, pre-euthanasia and euthanasia and scored the level of agitation on a scale of 0-3 (0 = 
none, 1 = mild, 2 = moderate, 3 = severe). Mice anesthetized with isoflurane displayed the 
highest  mean  scores  of  agitation  during  euthanasia.  The  level  of  agitation  produced  during 
induction  with midazolam  was  greater,  thought  not  statistically significant,  than the level  of 
agitation produced during euthanasia with all other agents except isoflurane. NA indicates no 
applicable data; Δ indicates a significant increase in agitation compared to pre-euthanasia and 
euthanasia time points for that group; ʦ indicates a significant increase in agitation compared to 
mice induced with acepromazine; * indicates a significant increase in  agitation compared to 
respective pre-euthanasia scores; Ω indicates a significant increase in agitation at euthanasia 
compared to mice treated with 20% V/min CO2, acepromazine, midazolam, or saline. P < 0.05. 
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Figure  6:  Behavioral  Dyspnea  Scores.    A  blinded  observer  examined  videotapes  taken  at 
induction, pre-euthanasia and euthanasia and scored the level of dyspnea on a scale of 0-3 (0 = 
none,  1  =  mild,  2  =  moderate,  3  =  severe).  Regardless  of  treatment,  all  groups  displayed 
significant dyspnea at the time of euthanasia  compared to either pre-euthanasia or induction 
levels. Mice anesthetized with isoflurane displayed the highest mean scores of dyspnea during 
euthanasia.  NA  indicates  no  applicable  data;  *  indicates  a  significant  increase  in  dyspnea 
compared  to  respective  pre-euthanasia  and  induction  score  (if  applicable);  ʱ  indicates  a 
significant increase in dyspnea compared to respective pre-euthanasia score. P < 0.05. 
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Ultrasonic sound recordings. 
Since mice can emit ultrasonic distress calls, ultrasonic sound recordings were taken to 
capture  any  altered  vocalizations  made  during  euthanasia.  All  pre-euthanasia  and  euthanasia 
sound spectrograms displayed sound peaks at 26.5 kHz that were not present in background 
noise control recordings in which no mice were present; therefore, this peak is presumed to be 
mouse  vocalization  (blue  arrows,  Figure  7).  Mice  euthanized  with  20%  V/min  CO2  or 
premedicated  with  acepromazine  had  euthanasia  spectrograms  that  were  identical  to  their 
respective pre-euthanasia spectrograms (Figure 7A and B). Mice premedicated with midazolam 
had an overall lower amplitude spectrogram during euthanasia for all data points greater than 7 
kHz, except at the 26.5 kHz vocalization peak (Figure 7C). This finding is consistent with the 
marked decreased activity noted in this group, but demonstrates that vocalization was not altered. 
The saline premedicated group had a higher amplitude spectrogram during euthanasia for all data 
points greater than 18 kHz consistent with increased activity and increased vocalization (Figure 
7D). Mice induced with isoflurane had a large increase in amplitude during euthanasia, which 
differed from the pre-euthanasia values for all data points greater than 8 kHz, including the 26.5 
kHz  vocalization  peak  (Figure  7E),  consistent  with  the  noted  agitation  in  this  group  and 
increased vocalization. Mice euthanized with 100% V/min CO2 had some fluctuations of higher 
amplitude during euthanasia (9-11 kHz, 13-18.6 kHz, 23-27 kHz, 28-32 kHz, and 33-37 kHz;  
some of which were similar to fluctuations seen in background noise control recordings of 100% 
V/min CO2 in which no mice were present (black arrow, Figure 7F); however, there was an 
increase at the 26.5 kHz vocalization peak similar to that noted in isoflurane treated mice.  32 
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Figure 7: Ultrasonic Sound Spectorgrams.  Pre-euthanasia recordings (red) were generated for 
two minutes prior to administration of gas. Euthanasia recordings (blue) were initiated at the 
beginning of gas administration and continued until all mice in the cage were unconscious. Each 
spectrogram represents the averaged value from two cages of mice from each group. All groups 
had a peak at 26.5 kHz (blue arrow) during both recordings which were absent when mice were 
not in the cage (black). This peak represents the only peak readily attributable to vocalization. 
Mice  euthanized  with  20%  V/min  CO2  (A)  or  administered  acepromazine  (B)  had  identical 
baseline pre-euthanasia and euthanasia recordings. In contrast, mice treated with midazolam (C) 
had lower decibel (dB) recordings in the 10-25 kHz range during euthanasia consistent with the 
heavy  sedation  and  decreased  movement  in  the  cage,  but  not  a  decrease  at  the  26.5  kHz 
vocalization peak. Mice administered saline (D), isoflurane (E), or 100% V/min CO2 (F) had 
higher amplitude recordings during euthanasia at the vocalization peak consistent with increased 
vocalization at euthanasia. Isoflurane (E) euthanasia also produced a large degree of background 
noise (10-26.5 kHz range) consistent with increased movement and agitation noted in this group. 
100% V/min CO2 (F) produced fluctuations in dB level (black arrow) which were also present 
when 100% V/min CO2 was provided to empty cages, indicating that these noises were likely the 
result of increased CO2 flow and not the mice. 
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Physiological measures of pain and stress.  
Plasma ACTH and corticosterone concentrations are commonly used to quantitatively 
assess  stress.    No  significant  differences  in  ACTH  concentration  were  noted  between  any 
treatment  groups  (Figure  8A).  In  contrast,  midazolam  treated  mice  had  significantly  higher 
corticosterone concentrations (147.9 ± 37.0 ng/ml) than all other groups, which ranged from 26.7 
± 9.0 to 65.8 ± 3.5 ng/ml (P < 0.05; Figure 8B). 
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Figure  8:  Plasma  ACTH  (A)  and  Corticosterone  (B)  Levels.  (mean  ±  SEM)  Mice  that 
received midazolam displayed a significant increase in corticosterone (*) but not ACTH, which 
was  suggestive  of  a  hypoxic  ACTH-independent  activation  of  adrenal  steroidogenesis.  This 
finding was consistent with the increased time to death following unconsciousness in this group. 
P < 0.05. 
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Neuromolecular measure of pain and stress.  
Increases in c-fos mRNA expression in the brain are a well established indicator of pain 
and stress in rodents (17; 26).  Since c-fos is expressed rapidly in association with a painful or 
stressful event, assessment of c-fos expression was used to evaluate acute pain or stress that may 
have been too early to  detect by plasma ACTH or corticosterone levels.  All premedication 
groups  and  the  isoflurane  anesthetized  group  displayed  significant  (P  <  0.05;  3-  to  7-fold) 
increases in c-fos expression when compared to either 20% or 100% V/min CO2 only groups 
(Figure  9).  There  was  little  to  no  difference  in  c-fos  expression  between  the  two  CO2 
concentrations.   
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Figure 9: Relative c-fos Levels in the Brain. (mean ± SEM) Both 20% and 100% CO2 treated 
groups expressed significantly less c-fos compared to all other groups (*). P < 0.05. 
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CHAPTER FIVE: 
CONCLUSION 
 
The  hypothesis  of  the  current  study  was  that  premedication  with  acepromazine, 
midazolam or isoflurane prior to CO2 euthanasia would alleviate pain and stress compared to 
CO2 administration alone in mice. The data described in this manuscript is in agreement with a 
similar study that assessed the use of sedation or anesthesia prior to CO2 euthanasia of rats (24). 
Specifically, premedication of mice did not provide any advantage over the use of CO2 alone, as 
it  did  not  decrease  behavioral,  physiological,  or  neuromolecular  markers  of  pain  or  stress. 
Furthermore, all parameters of pain or stress assessed were minimal in mice euthanized with CO2 
at a flow rate of 20% air displacement per minute. In addition, to our knowledge, this is the first 
study that provides direct quantifiable evidence that isoflurane induction is more stressful to 
mice than euthanasia with CO2 alone at the flow rates of 20 or 100% V/min. 
Numerous studies, primarily using rats, have attempted to determine if CO2 is a humane 
and acceptable method of euthanasia, however there has been great variation in methodology. 
The major questions that remain over the use of CO2 for euthanasia stem from the ability of CO2 
to induce pain in human (2; 14; 30; 38) and rodent studies (40; 62; 75). Unfortunately, the 
manner in which those studies were conducted differs greatly from the way that rodents are 
commonly euthanized with CO2 in that specific concentrations of CO2 were applied directly on 
mucosal surfaces (2; 14; 30; 38; 40; 62; 75). In a human study, the mean concentration of CO2 
that was reported to induce pain was 47.1% (2); similarly in a study utilizing rats, nociceptors in 
the nasal mucosa responded to concentrations of 37 to 50% CO2, although no assessment of pain 36 
 
was  made  (62).  Human  subjects  reported  that  increasing  concentrations  of  CO2  were 
progressively  more  noxious,  with  50%  V/min  CO2  being  considered  “highly  unpleasant” 
bordering on “uncomfortable” and 100% V/min CO2 being rated as “painful” (14). In contrast to 
the conduct of those studies, our mice experienced a chamber filled with 100% CO2 mixed with 
ambient  air  at  a  specified  flow  rate  (20%  V/min  displacement).    Mice  generally  lost 
consciousness ~ two minutes after initiation of CO2 indicating that they lost consciousness prior 
to  concentrations  (~50%)  which  are  reported  to  be  painful  in  humans.  Specifically, 
concentrations of CO2 achieved in the cage after two minutes of treatment would reach ~ 40%.  
Thus, gradually filling the cage with CO2 achieves unconsciousness prior to the dose that is 
reported to be painful in humans.   
In CO2 euthanasia studies, despite the same behaviors being described, some observers 
would describe the animals as experiencing no pain or stress while others would conclude that 
the animals  experienced significant pain or stress (12; 14). To avoid basing recommendations on 
subjective data alone, objective measures of pain and stress have also been evaluated, including 
heart  rate  and  blood  pressure  monitoring,  plasma  ACTH,  corticosterone,  and  glucose  level 
quantifications, and ultrasonic vocalizations, which supported the notion that CO2 is a humane 
method of euthanasia in rodents (9; 24; 71).  
Acepromazine was chosen for the current study because it is one of the most commonly 
used tranquilizers in veterinary medicine. There are species-specific differences in the reported 
effectiveness of acepromazine prior to euthanasia. Specifically, in dogs it reduces agitation (13), 
however, in rats no beneficial effect is noted (24). In the present study, the use of acepromazine 
did provide some beneficial effect in that it reduced time to unconsciousness, but this benefit was 37 
 
negated by the marked increase in c-fos expression likely associated with the stress of handling 
and injection.  
Midazolam was chosen for this study because it is a fast-acting anxiolytic with heavy 
sedative  properties.  Similar  to  acepromazine,  midazolam  significantly  decreased  the  time  to 
unconsciousness, however, there was a significant increase in time to death compared to all other 
euthanasia groups except isoflurane. The increased time to death following unconsciousness may 
be  explained  by  the  mechanism  of  action  of  midazolam,  which  increases  the  efficiency  of 
gamma-aminobutyric  acid  (GABA),  an  inhibitory  neurotransmitter  in  the  brain.  GABA  is 
neuroprotective  against  ischemia  during  hypoxia  (69;  79)  and  the  protective  effects  of 
GABAergic drugs, such as midazolam, against neural hypoxic damage may have prolonged the 
time to death in these mice.  
Induction with midazolam caused a significantly higher level of agitation compared to 
induction with acepromazine, and a higher level of agitation, albeit not statistically significant, 
than seen during euthanasia with 20% V/min CO2 alone. This increase in agitation at induction is 
likely  due  to  paradoxical  excitement  that  is  occasionally  seen  with  sedative  doses  of 
benzodiazepines,  such  as  midazolam.  This  benzodiazepine-induced  excitation  has  been 
demonstrated in numerous species including humans and may include restlessness, agitation, 
violent behavior, and self-mutilation (22; 31; 48). The mechanism of action for this reaction is 
unknown.  
Mice pretreated with midazolam had ACTH levels that were comparable to the other 
treatment groups; however, corticosterone levels were significantly increased.  This finding is 
suggestive of a hypoxic ACTH-independent activation of adrenal steroidogenesis (64). Elevation 
of corticosterone only in the midazolam treated group was consistent with the extended time 38 
 
period of hypoxia that the group was exposed to during the prolonged time to death. The c-fos 
levels in the midazolam treated group were the highest of all the groups, 7.7-fold higher than the 
control.  Because of neuromolecular and behavioral indicators of stress being elevated in this 
group, and because of the marked increase in time to death, it does not appear to provide any 
benefit as a premedication for euthanasia. These data are similar to studies in rats which indicate 
that sedation with  oral acepromazine or anesthesia with pentobarbital (IP injection) did not 
appreciably alter behavioral or biochemical parameters of pain in rats euthanized with CO2 (24).  
Similar to midazolam and acepromazine treatment, saline treated mice upregulated c-fos 
expression which is consistent with increased stress. These findings indicate that the stress of 
handling is more potent then the stress of CO2 euthanasia itself. These findings imply that there 
are fundamental differences between mice and standard companion animals. That is, standard 
pre-euthanasia regimes that reduce stress in companion species appear deleterious in animals in 
which human contact and handling itself is viewed as a stressful event.   
Anesthetic induction with isoflurane prior to CO2 euthanasia was conducted in this study 
based on current recommendations within the CCAC guidelines on euthanasia of animals used in 
science.  According to the CCAC, where practical, animals should be anesthetized, preferably 
with an inhalant anesthetic, prior to the use of CO2 (10). The two studies that were cited in 
support of this recommendation used approach-avoidance tests to assess rodent aversion to gas 
stimuli (41; 47). However, one study assessed rat and mouse aversion to pre-filled chambers of 
CO2, CO2/Ar mixture, or Ar without the presence of a food reward in the test chamber (41), 
while the other study compared rat aversion to gradual fill halothane or isoflurane with a food 
reward in the test chamber (47). In the CO2/Ar study, the authors concluded that induction with 
CO2 either alone or in combination with Ar is likely to cause considerable distress in rodents 39 
 
before they lose consciousness (41). This finding was based upon significantly shorter initial 
withdrawal times and total dwelling times in the test chamber that was pre-filled with CO2 at 
concentrations  that  ranged  from  25.5  to  50.8%  compared  to  the  control  of  room  air.  The 
halothane/isoflurane study concluded that both inhalant anesthetics were aversive to rats (47).  
However, because some of the rats remained in the test cage long enough to become ataxic, the 
authors concluded that the rats were likely in a state of conscious sedation at the time they chose 
to  leave  the  test  cage,  therefore,  continued  forced  exposure  from  the  onset  of  aversion  to 
unconsciousness may be more humane than forced exposure to CO2. The two studies were not 
comparable in their design (pre-fill vs. gradual fill; no food reward vs. food reward), and neither 
study directly compared aversion of CO2 to isoflurane. In addition, both of these studies did not 
involve euthanizing the rodents and did not assess any direct or indirect indicators of pain or 
stress.   
In the present study, the hypothesis that isoflurane anesthesia prior to CO2 euthanasia 
would  decrease  the  level  of  pain  or  stress  experienced  with  CO2  alone  was  directly  tested. 
Interestingly, isoflurane induction resulted in the need for a longer CO2 exposure at greater than 
100% V/min than the use of 100% V/min CO2 alone. This increase in time to death during CO2 
exposure, despite the higher concentration of CO2, is likely due to the hypothermic effect of 
general anesthesia which has been shown to be neuroprotective during hypoxia (19; 69).  
Isoflurane was the highest scoring group for both dyspnea and agitation, which were 
significantly higher than pre-gas exposure scores, and produced significantly higher scores of 
agitation than the 20% V/min CO2 group during euthanasia. The ultrasonic spectrogram also 
reflected  elevated  movement  within  the  cage,  indicative  of  agitation,  and  increased  mouse 
vocalization  at  the  26.5  kHz  peak,  potentially  indicative  of  stress  induced  vocalization.  40 
 
Additionally, c-fos expression was increased significantly, 6-fold higher than the 20% V/min 
CO2 group.  
An  additional  negative  effect  of  isoflurane  is  that  some  mice  awoke  after  isoflurane 
induction and during the euthanasia phase. This finding highlights a weakness in the CCAC 
recommendation, in that, due to the rapid recovery from isoflurane mice may recover once the 
isoflurane is removed and CO2 is initiated. Indeed, with newer gas anesthetics (eg., sevoflurane) 
this may become even more of an issue. Previous studies that recommended the use of isoflurane 
prior to CO2 euthanasia (45; 47) do not account for the rapid recovery from isoflurane that occurs 
while the chamber is filling with CO2, and since they were merely avoidance tests, they missed 
altogether  the  possibility  of  pain  or  stress  associated  with  anesthetic  induction.  In  short, 
isoflurane, in the current study, was the worst option with regard to minimizing animal pain or 
stress.  
A group of mice euthanized with CO2 at a flow rate of 100% air displacement per minute 
was included in this study because the current AVMA recommendation describes > 20% CO2 V 
displacement per minute.  Time to unconsciousness and time to death were significantly faster 
than the 20% V/min CO2 control.  However, dyspnea and agitation scores were higher than the 
control,  although  not  significantly,  and  the  ultrasonic  spectrogram  showed  elevations  in 
amplitude during the euthanasia recording that were not present in the pre-euthanasia recording.  
These behavioral responses suggest a trend toward increased pain or stress with increased flow 
rate; however, ACTH, corticosterone, and c-fos levels were comparable to the 20% V/min CO2 
control. Further, because mice were still conscious in the cage during the timeframe when the 
CO2 concentration exceeded 50%, there is a possibility that mice experienced mucosal pain from 41 
 
CO2 at this flow rate. Based upon these data it may be worthwhile to evaluate higher CO2 flow 
rates in future studies to determine the recommended upper flow rate limit for euthanasia.     
Data which call into question the humane nature of rodent CO2 euthanasia generally fall 
into two categories: those that rely on human studies indicating that CO2 at high concentrations 
is painful, and those that rely on approach-avoidance tests. With regard to the former, our data 
indicate that with 20% V/min flow rates mice reach unconsciousness prior to the buildup of 
painful concentrations of CO2. With regard to the latter, we suggest that approach-avoidance 
tests are not ideal tests to determine a humane euthanasia method. Specifically, aversion does not 
necessarily  indicate  pain  or  stress.  In  fact,  there  are  several  examples  supporting  this. 
Specifically, a brief puff of air induces aversion in mice (77) and urine collected from male mice 
infected with Polyplax serrata induces aversion in female mice (32). In these examples, non-
conditioned avoidance/aversion responses are not necessarily indicators of pain or stress, but 
rather evolutionary survival cues (puff of air = predator, infected mouse urine = poor mate). 
Indeed,  non-conditioned  CO2  avoidance  is  evolutionarily  conserved  (presumably  to  avoid 
hypoxic death) and can be demonstrated in organisms as diverse as nematodes (Caenorhabditis 
elegans), Drosophilla, fish, and in mice which can actually sense CO2 concentrations at near 
atmospheric levels (i.e., far below those which would ever be reported as painful or unpleasant in 
humans) (7; 28; 29; 44; 73). Further, approach-avoidance tests fail to adequately distinguish 
between stressors, which are not  necessarily negative, and distress,  which is  the inability to 
appropriately respond (either behaviorally or physiologically) to those stressors (56; 70). That is, 
just because an animal encounters an external stressor (e.g., puff of air, mouse urine, CO2) and 
chooses to avoid it does not mean that distress is induced. Our data would indicate that from a 42 
 
behavioral,  physiological,  and  neuromolecular  level,  overt  distress  does  not  occur  with  CO2 
euthanasia at the 20% V/min flow rate tested.     
In summary, the present study demonstrates that premedication with acepromazine or 
midazolam prior to CO2 euthanasia did not improve euthanasia with respect to animal welfare, 
and based on neuromolecular markers, induced greater stress then CO2 alone. Furthermore, the 
use  of  isoflurane  induction  prior  to  CO2  euthanasia  significantly  increased  behavioral  and 
neuromolecular indicaters of pain and stress. These data show that in comparison to the other 
modalities analyzed in this study, 20% V/min CO2 alone is a humane euthanasia method which is 
not associated with increases in behavioral, ultrasonic, physiologic or neuromolecular markers of 
pain or stress in mice. 
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